vTv Therapeutics (VTVT)
27.54
-0.23 (0.83%)
Upcoming Events
Latest Headlines
iOnctura appoints Paul Sekhri as Chair of its Board of Directors
October 15, 2026 3:30 AM - Globe NewsWire
vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
October 10, 2026 8:00 AM - StreetInsider
Form SCHEDULE 13G/A vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC
October 8, 2026 6:27 PM - SEC Filing
vTv Therapeutics stock jumps on FDA orphan drug status
October 8, 2026 9:18 AM - StreetInsider
FDA grants orphan drug status to vTv Therapeutics' sickle cell drug
October 7, 2026 4:11 PM - StreetInsider
vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease
October 7, 2026 4:01 PM - StreetInsider
Form 8-K vTv Therapeutics Inc. For: Oct 01
October 6, 2026 4:32 PM - SEC Filing
vTv Therapeutics to host KOL event on type 1 diabetes drug program
October 6, 2026 8:00 AM - StreetInsider
vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026
October 6, 2026 8:00 AM - StreetInsider
vTv Therapeutics completes enrollment in Phase 3 type 1 diabetes trial
October 5, 2026 8:00 AM - StreetInsider
vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
October 5, 2026 8:00 AM - StreetInsider
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 15, 2026 4:05 PM - StreetInsider
vTv Therapeutics to Participate in September Investor Conferences
September 2, 2026 8:00 AM - StreetInsider
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 19, 2026 4:05 PM - StreetInsider
Form 10-Q vTv Therapeutics Inc. For: Jun 30
August 6, 2026 4:33 PM - SEC Filing
Form 8-K vTv Therapeutics Inc. For: Aug 06
August 6, 2026 4:26 PM - SEC Filing
vTv Therapeutics (VTVT) Misses Q2 EPS by 15c
August 6, 2026 8:17 AM - StreetInsider
vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G/A vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC
July 29, 2026 6:45 PM - SEC Filing
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 28, 2026 4:05 PM - StreetInsider
Full Article List
